SERTAD1 and breast carcinoma: qPCR analysis confirmed the upregulation of BRCA1, cGAS, STING, SEI1, and PD‐L1 expressions in the breast cancer cell lines (Figure S12A,B, Supporting Information) or lymphoma cell lines (Figure S12C–F, Supporting Information) treated with melphalan or bortezomib.